Login / Signup

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Toni T SeppäläAysel AhadovaMev Dominguez-ValentinFinlay MacraeD Gareth EvansChristina TherkildsenJulian SampsonRodney ScottJohn BurnGabriela MösleinInge BernsteinElke Holinski-FederKirsi PylvänäinenLaura Renkonen-SinisaloAnna LepistöCharlotte Kvist LautrupAnnika LindblomJohn-Paul PlazzerIngrid WinshipDouglas TjandraLior H KatzStefan AretzRobert HüneburgStefanie HolzapfelKarl HeinimannAdriana Della ValleFlorencia NeffaNathan GluckWouter H de Vos Tot Nederveen CappelHans VasenMonika MorakVerena Steinke-LangeChristoph EngelNils RahnerWolff SchmiegelDeepak VangalaHuw ThomasKate GreenFiona LallooEmma J CrosbieJames HillGabriel CapellaMarta PinedaMatilde NavarroIgnacio BlancoSanne Ten BroekeMaartje NielsenKen LjungmannSigve NakkenNoralane LindorIan FraylingEivind HovigLone SundeMatthias KloorJukka-Pekka MecklinMette KalagerPål Møller
Published in: Hereditary cancer in clinical practice (2019)
The CRC stage and interval since last colonoscopy were not correlated, which is in conflict with the accelerated adenoma-carcinoma paradigm. We have previously reported that more frequent colonoscopy is not associated with lower incidence of CRC in path_MMR carriers as was expected. In contrast, point estimates showed a higher incidence with shorter intervals between examinations, a situation that may parallel to over-diagnosis in breast cancer screening. Our findings raise the possibility that some CRCs in path_MMR carriers may spontaneously disappear: the host immune response may not only remove CRC precursor lesions in path_MMR carriers, but may remove infiltrating cancers as well. If confirmed, our suggested interpretation will have a bearing on surveillance policy for path_MMR carriers.
Keyphrases